Martin Haluzík (Martin Haluzik)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 36

Top Venues

Diabetes therapy : research, treatment and education of diabetes and related disorders

Diabetes, obesity & metabolism

Diabetes care

Drugs

Institute for Clinical and Experimental Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute for Clinical and Experimental Medicine

Czechia

professor :: Diabetes Centre

Publications

Luděk Horváth, Milos Mraz, Edward B Jude, Martin Haluzík
Pharmacotherapy as an Augmentation to Bariatric Surgery for Obesity. Drugs 84 (8) (2024)
Martin Haluzík, Zoltan Taybani, Aleksandra Araszkiewicz, Anca Cerghizan, Boris Mankovsky, Agbaria Zuhdi, Maciej Malecki
Expert Opinion on Optimising Type 2 Diabetes Treatment Using Fixed-Ratio Combination of Basal Insulin and GLP-1 RA for Treatment Intensification and Simplification. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (8) (2024)
Luděk Horváth, Milos Mraz, Edward B Jude, Martin Haluzík
Pharmacotherapy as an Augmentation to Bariatric Surgery for Obesity. Drugs 84 (8) (2024)
Peter Novodvorsky, Lenka Thieme, Ivana Laňková, Miloš Mráz, Zoltán J Taybani, Balázs Bótyik, Péter Stella, Miroslav Vytasil, Felipe Lauand, Mireille Bonnemaire, Martin Haluzík
The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial-Study Design and Protocol. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (6) (2024)
Barbora Judita Kasperova, Milos Mraz, Petr Svoboda, Daniel Hlavacek, Helena Kratochvilova, Istvan Modos, Nikola Vrzackova, Peter Ivak, Petra Janovska, Tatyana Kobets, Jakub Mahrik, Martin Riecan, Lenka Steiner Mrazova, Viktor Stránecký, Ivan Netuka, Tomáš Čajka, Ondřej Kuda, Vojtech Melenovsky, Sona Stemberkova Hubackova, Martin Haluzík
Sodium-glucose cotransporter 2 inhibitors induce anti-inflammatory and anti-ferroptotic shift in epicardial adipose tissue of subjects with severe heart failure. Cardiovascular diabetology 23 (1) (2024)
Jochen Seufert, Nick Freemantle, Cristian Guja, Martin Haluzík, Mathilde Tournay, Carine Vera, Mireille Bonnemaire, Janos T Kis
Real-life effectiveness of iGlarLixi (insulin glargine 100 U/mL and lixisenatide) in people with type 2 diabetes according to prior insulin use. Diabetes, obesity & metabolism 26 (7) (2024)
Peter Novodvorsky, Lenka Thieme, Ivana Laňková, Miloš Mráz, Zoltán J Taybani, Balázs Bótyik, Péter Stella, Miroslav Vytasil, Felipe Lauand, Mireille Bonnemaire, Martin Haluzík
The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial-Study Design and Protocol. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (6) (2024)
Barbora Voglová, Marek Protuš, Lenka Nemetova, Milos Mraz, Eva Kieslichova, Eva Uchytilová, Veronika Indrova, Jan Lelito, Peter Girman, Martin Haluzík, Janka Franeková, Veronika Svirlochova, David C Klonoff, Michael A Kohn, Antonin Jabor
Accuracy and Feasibility of Real-time Continuous Glucose Monitoring in Critically Ill Patients After Abdominal Surgery and Solid Organ Transplantation. Diabetes care 47 (6) (2024)
Peter Novodvorsky, Lenka Thieme, Ivana Laňková, Miloš Mráz, Zoltán J Taybani, Balázs Bótyik, Péter Stella, Miroslav Vytasil, Felipe Lauand, Mireille Bonnemaire, Martin Haluzík
The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial-Study Design and Protocol. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (6) (2024)
Martin Haluzík, Zoltan Taybani, Aleksandra Araszkiewicz, Anca Cerghizan, Boris Mankovsky, Agbaria Zuhdi, Maciej Malecki
Expert Opinion on Optimising Type 2 Diabetes Treatment Using Fixed-Ratio Combination of Basal Insulin and GLP-1 RA for Treatment Intensification and Simplification. Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)
Jochen Seufert, Nick Freemantle, Cristian Guja, Martin Haluzík, Mathilde Tournay, Carine Vera, Mireille Bonnemaire, Janos T Kis
Real-life effectiveness of iGlarLixi (insulin glargine 100 U/mL and lixisenatide) in people with type 2 diabetes according to prior insulin use. Diabetes, obesity & metabolism (2024)
Barbora Voglová, Marek Protuš, Lenka Nemetova, Milos Mraz, Eva Kieslichova, Eva Uchytilová, Veronika Indrova, Jan Lelito, Peter Girman, Martin Haluzík, Janka Franeková, Veronika Svirlochova, David C Klonoff, Michael A Kohn, Antonin Jabor
Accuracy and Feasibility of Real-time Continuous Glucose Monitoring in Critically Ill Patients After Abdominal Surgery and Solid Organ Transplantation. Diabetes care 47 (6) (2024)
Luděk Horváth, Milos Mraz, Edward B Jude, Martin Haluzík
Pharmacotherapy as an Augmentation to Bariatric Surgery for Obesity. Drugs (2024)
Barbora Voglová, Marek Protuš, Lenka Nemetova, Milos Mraz, Eva Kieslichova, Eva Uchytilová, Veronika Indrova, Jan Lelito, Peter Girman, Martin Haluzík, Janka Franeková, Veronika Svirlochova, David C Klonoff, Michael A Kohn, Antonin Jabor
Accuracy and Feasibility of Real-time Continuous Glucose Monitoring in Critically Ill Patients After Abdominal Surgery and Solid Organ Transplantation. Diabetes care (2024)
Martin Haluzík, Zoltan Taybani, Aleksandra Araszkiewicz, Anca Cerghizan, Boris Mankovsky, Agbaria Zuhdi, Maciej Malecki
Expert Opinion on Optimising Type 2 Diabetes Treatment Using Fixed-Ratio Combination of Basal Insulin and GLP-1 RA for Treatment Intensification and Simplification. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (8) (2024)
Barbora Judita Kasperova, Milos Mraz, Petr Svoboda, Daniel Hlavacek, Helena Kratochvilova, Istvan Modos, Nikola Vrzackova, Peter Ivak, Petra Janovska, Tatyana Kobets, Jakub Mahrik, Martin Riecan, Lenka Steiner Mrazova, Viktor Stránecký, Ivan Netuka, Tomáš Čajka, Ondřej Kuda, Vojtech Melenovsky, Sona Stemberkova Hubackova, Martin Haluzík
Sodium-glucose cotransporter 2 inhibitors induce anti-inflammatory and anti-ferroptotic shift in epicardial adipose tissue of subjects with severe heart failure. Cardiovascular diabetology 23 (1) (2024)
Martin Haluzík, Zoltan Taybani, Aleksandra Araszkiewicz, Anca Cerghizan, Boris Mankovsky, Agbaria Zuhdi, Maciej Malecki
Expert Opinion on Optimising Type 2 Diabetes Treatment Using Fixed-Ratio Combination of Basal Insulin and GLP-1 RA for Treatment Intensification and Simplification. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (8) (2024)
Martin Haluzík, Mohammed E Al-Sofiani, Alice Y Y Cheng, Felipe Lauand, Lydie Melas-Melt, Julio Rosenstock
Time-in-range derived from self-measured blood glucose in people with type 2 diabetes advancing to iGlarLixi: A participant-level pooled analysis of three phase 3 LixiLan randomized controlled trials. Diabetes, obesity & metabolism (2024)
Peter Novodvorsky, Lenka Thieme, Ivana Laňková, Miloš Mráz, Zoltán J Taybani, Balázs Bótyik, Péter Stella, Miroslav Vytasil, Felipe Lauand, Mireille Bonnemaire, Martin Haluzík
The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial-Study Design and Protocol. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (6) (2024)
Peter Novodvorsky, Lenka Thieme, Ivana Laňková, Miloš Mráz, Zoltán J Taybani, Balázs Bótyik, Péter Stella, Miroslav Vytasil, Felipe Lauand, Mireille Bonnemaire, Martin Haluzík
The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial-Study Design and Protocol. Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)
Luděk Horváth, Milos Mraz, Edward B Jude, Martin Haluzík
Pharmacotherapy as an Augmentation to Bariatric Surgery for Obesity. Drugs 84 (8) (2024)
Barbora Voglová, Marek Protuš, Lenka Nemetova, Milos Mraz, Eva Kieslichova, Eva Uchytilová, Veronika Indrova, Jan Lelito, Peter Girman, Martin Haluzík, Janka Franeková, Veronika Svirlochova, David C Klonoff, Michael A Kohn, Antonin Jabor
Accuracy and Feasibility of Real-time Continuous Glucose Monitoring in Critically Ill Patients After Abdominal Surgery and Solid Organ Transplantation. Diabetes care 47 (6) (2024)
Eliska Vacurova, Jaroslava Trnovska, Petr Svoboda, Vojtech Skop, Vendula Novosadova, David Pajuelo Reguera, Silvia Petrezsélyová, Benoit Piavaux, Berwini Endaya, Frantisek Spoutil, Dagmar Zudova, Jan Stursa, Magdalena Melcova, Zuzana Bielcikova, Lukas Werner, Jan Prochazka, Radislav Sedlacek, Martina Huttl, Sona Stemberkova Hubackova, Martin Haluzík, Jiri Neuzil
Mitochondrially targeted tamoxifen alleviates markers of obesity and type 2 diabetes mellitus in mice. Nature communications 13 (1) (2022)
Vanita R Aroda, Robert Bauer, Erik Christiansen, Martin Haluzík, Klaus Kallenbach, Eduard Montanya, Julio Rosenstock, Juris J Meier
Efficacy and safety of oral semaglutide by subgroups of patient characteristics in the PIONEER phase 3 programme. Diabetes, obesity & metabolism 24 (7) (2022)
Martina Hüttl, Irena Markova, Denisa Miklankova, Iveta Zapletalová, Martin Poruba, Martin Haluzík, Ivana Vaněčkova, Hana Malinska
In a Prediabetic Model, Empagliflozin Improves Hepatic Lipid Metabolism Independently of Obesity and before Onset of Hyperglycemia. International journal of molecular sciences 22 (21) (2021)
Jan Král, Evžen Machytka, Veronika Horká, Jana Selucká, Filip Doleček, Julius Špičák, Viktorie Kovářová, Martin Haluzík, Marek Buzga
Endoscopic Treatment of Obesity and Nutritional Aspects of Bariatric Endoscopy. Nutrients 13 (12) (2021)
Petra Janovska, Vojtech Melenovsky, Michaela Svobodova, Tereza Tykvartova, Helena Kratochvilova, Martin Haluzík, Eva Hoskova, Terezie Pelikanova, Josef Kautzner, Luca Monzo, Ivana Jurcova, Katerina Adamcova, Lucie Lenkova, Jana Buresova, Martin Rossmeisl, Ondřej Kuda, Tomáš Čajka, Jan Kopecky
Dysregulation of epicardial adipose tissue in cachexia due to heart failure: the role of natriuretic peptides and cardiolipin. Journal of cachexia, sarcopenia and muscle 11 (6) (2020)
Giorgio Sesti, Lars Bardtrum, Selcuk Dagdelen, Natalie Halladin, Martin Haluzík, Petra Őrsy, Martin Rodríguez, Vanita R Aroda
A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII, a randomized trial designed to resemble clinical practice. Diabetes, obesity & metabolism 22 (5) (2020)
Martin Haluzík, Alice Cheng, Dirk Müller-Wieland, Jukka Westerbacka, Zsolt Bosnyak, Felipe Lauand, Lydie Melas-Melt, Janaka Karalliedde, Julio Rosenstock, Geremia B Bolli
Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial. Diabetes, obesity & metabolism 22 (8) (2020)
Vanita R Aroda, Julio Rosenstock, Yasuo Terauchi, Yuksel Altuntas, Nebojsa M Lalic, Enrique C Morales Villegas, Ole K Jeppesen, Erik Christiansen, Christin L Hertz, Martin Haluzík, null null
PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes. Diabetes care 42 (9) (2019)
Miloš Mráz, Anna Cinkajzlová, Jana Kloučková, Zdeňka Lacinová, Helena Kratochvílová, Michal Lipš, Michal Pořízka, Petr Kopecký, Jaroslav Lindner, Tomáš Kotulák, Ivan Netuka, Martin Haluzík
Dendritic Cells in Subcutaneous and Epicardial Adipose Tissue of Subjects with Type 2 Diabetes, Obesity, and Coronary Artery Disease. Mediators of inflammation 2019 (2019)
Miloš Mráz, Anna Cinkajzlová, Jana Kloučková, Zdeňka Lacinová, Helena Kratochvílová, Michal Lipš, Michal Pořízka, Petr Kopecký, Aneta Pierzynová, Tomáš Kučera, Vojtěch Melenovský, Ilja Stříž, Jaroslav Lindner, Martin Haluzík
Coronary Artery Disease Is Associated with an Increased Amount of T Lymphocytes in Human Epicardial Adipose Tissue. Mediators of inflammation 2019 (2019)
Martin Haluzík, Adam Kretowski, Krzysztof Strojek, Leszek Czupryniak, Andrej Janez, Peter Kempler, Michal Andel, Tsvetalina Tankova, Mihail Boyanov, Lea Smircic Duvnjak, Laszlo Madacsy, Iwona Tarnowska, Marcin Zychma, Nebojsa Lalic
Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries. Diabetes therapy : research, treatment and education of diabetes and related disorders 9 (2) (2018)
Martin Haluzík, Miloš Mráz
Intermittent Fasting and Prevention of Diabetic Retinopathy: Where Do We Go From Here? Diabetes 67 (9) (2018)
Martin Haluzík, Greg Fulcher, Thomas R Pieber, Lars Bardtrum, Deniz Tutkunkardas, Helena W Rodbard
The co-formulation of insulin degludec and insulin aspart lowers fasting plasma glucose and rates of confirmed and nocturnal hypoglycaemia, independent of baseline glycated haemoglobin levels, disease duration or body mass index: A pooled meta-analysis of phase III studies in patients with type 2 diabetes. Diabetes, obesity & metabolism 20 (7) (2018)
Michal Lipš, Miloš Mráz, Jana Kloučková, Petr Kopecký, Miloš Dobiáš, Jarmila Křížová, Jaroslav Lindner, Michaela Diamant, Martin Haluzík
Effect of continuous exenatide infusion on cardiac function and peri-operative glucose control in patients undergoing cardiac surgery: A single-blind, randomized controlled trial. Diabetes, obesity & metabolism 19 (12) (2017)

Martin Haluzík.css-eqlu8i{font-size:small;padding-left:4px;} (Martin Haluzik)

Publication Activity (10 Years)

Top Topics

Top Venues

Martin Haluzík (Martin Haluzik)